Quest Patent Research (QPRC) Cash & Equivalents (2016 - 2026)
On a quarterly basis, Cash & Equivalents rose 1196.18% to $619861.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $619861.0, a 1196.18% increase, with the full-year FY2025 number at $192606.0, down 60.04% from a year prior.
Quest Patent Research's Cash & Equivalents history spans 18 years, with the latest figure at $619861.0 for Q1 2026.
- Cash & Equivalents came in at $619861.0 for Q1 2026, up from $192606.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $770696.0 in Q1 2024, with the low at $47822.0 in Q1 2025.
- Historically, Cash & Equivalents has averaged $288006.9 across 5 years, with a median of $192606.0 in 2025.
- Biggest five-year swings in Cash & Equivalents: tumbled 93.79% in 2025 and later skyrocketed 1196.18% in 2026.
- Year by year, Cash & Equivalents stood at $90601.0 in 2022, then skyrocketed by 521.94% to $563484.0 in 2023, then decreased by 14.46% to $482023.0 in 2024, then plummeted by 60.04% to $192606.0 in 2025, then surged by 221.83% to $619861.0 in 2026.
- Business Quant data shows Cash & Equivalents for QPRC at $619861.0 in Q1 2026, $192606.0 in Q4 2025, and $175141.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | 174.25 Mn |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | 1.39 Bn |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 183.20 Mn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 5.10 Bn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 258.00 Mn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | 5.86 Bn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 192.20 Mn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 475.72 Mn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 428.00 Mn |
| 10 | Quest Patent Research | - | - | -1.71 Mn | 619,861.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 619,861.00 |
| Dec 31, 2025 | 192,606.00 |
| Sep 30, 2025 | 175,141.00 |
| Jun 30, 2025 | 254,659.00 |
| Mar 31, 2025 | 47,822.00 |
| Dec 31, 2024 | 482,023.00 |
| Sep 30, 2024 | 136,782.00 |
| Jun 30, 2024 | 136,767.00 |
| Mar 31, 2024 | 770,696.00 |
| Dec 31, 2023 | 563,484.00 |
| Sep 30, 2023 | 611,466.00 |
| Jun 30, 2023 | 128,497.00 |
| Mar 31, 2023 | 126,906.00 |
| Dec 31, 2022 | 90,601.00 |
| Sep 30, 2022 | 75,968.00 |
| Jun 30, 2022 | 228,164.00 |
| Mar 31, 2022 | 254,674.00 |
| Dec 31, 2021 | 264,840.00 |
| Sep 30, 2021 | 213,880.00 |
| Jun 30, 2021 | 160,731.00 |
| Mar 31, 2021 | 227,015.00 |
| Dec 31, 2020 | 247,862.00 |
| Sep 30, 2020 | 91,879.00 |
| Jun 30, 2020 | 862,367.00 |
| Mar 31, 2020 | 551,636.00 |
| Dec 31, 2019 | 537,198.00 |
| Sep 30, 2019 | 344,386.00 |
| Jun 30, 2019 | 416,477.00 |
| Mar 31, 2019 | 120,775.00 |
| Dec 31, 2018 | 166,911.00 |
| Sep 30, 2018 | 37,589.00 |
| Jun 30, 2018 | 16,739.00 |
| Mar 31, 2018 | 16,508.00 |
| Dec 31, 2017 | 165,546.00 |
| Sep 30, 2017 | 142,541.00 |
| Jun 30, 2017 | 14,372.00 |
| Mar 31, 2017 | 70,842.00 |
| Dec 31, 2016 | 208,324.00 |
| Sep 30, 2016 | 157,570.00 |
| Jun 30, 2016 | 89,766.00 |